LEADER 00938nam0-2200277---450- 001 990009777200403321 005 20131021185209.0 035 $a000977720 035 $aFED01000977720 035 $a(Aleph)000977720FED01 035 $a000977720 100 $a20131021d1886----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $a--------001yy 200 1 $aTesto unico del regolamento sull'amministrazione e sulla contabilità generale dello stato$eapprovato col R. Decreto 4 maggio 1885, num. 3074$fAdriano De Cupis 210 $aTorino$cUnione tipografico-editrice$d1886 215 $a500 p.$d22 cm 700 1$aDe Cupis,$bAdriano$f<1845-1930>$0437598 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990009777200403321 952 $aDT I-179$bD2744$fDEC 959 $aDEC 996 $aTesto unico del regolamento sull'amministrazione e sulla contabilità generale dello stato$9832415 997 $aUNINA LEADER 01703nam 2200433 n 450 001 996390704203316 005 20200824120443.0 035 $a(CKB)4940000000099297 035 $a(EEBO)2248499497 035 $a(UnM)99828284e 035 $a(UnM)99828284 035 $a(EXLCZ)994940000000099297 100 $a19950407d1665 uy | 101 0 $aeng 135 $aurbn||||a|bb| 200 14$aThe dying mans last sermon. Or, The fathers last blessing$b[electronic resource] $eLeft, and bequeathed as a legacy unto his children, immediately before his death. Being comfortable meditations and preparations for the day of death; which for the worth of them are more worthy to be written in letters of gold, then with ink and paper. The twelfth edition with additions, by Andrew Jones, a servant of Jesus Christ 210 $aLondon $cprinted for Elizabeth Andrews, at the White Lion near Pye-Corner$d1665 215 $a[22] p 300 $aAttributed (erroneously?) to John Hart, by Wing. 300 $aSignatures: A [-A1?], B?. 300 $aReproduction of the original in the British Library. 330 $aeebo-0018 606 $aChristian life$vEarly works to 1800 606 $aConduct of life$vEarly works to 1800 606 $aDeath$vEarly works to 1800 615 0$aChristian life 615 0$aConduct of life 615 0$aDeath 700 $aJones$b Andrew$cM.A.$0569681 702 $aHart$b John$cD.D., 801 0$bCu-RivES 801 1$bCu-RivES 801 2$bUk-ES 801 2$bCStRLIN 801 2$bWaOLN 906 $aBOOK 912 $a996390704203316 996 $aThe dying man's last sermon. Or The Fathers last blessing$92314684 997 $aUNISA LEADER 05601nam 22006615 450 001 9910300210103321 005 20250709140227.0 010 $a1-4939-1881-8 024 7 $a10.1007/978-1-4939-1881-2 035 $a(CKB)3710000000281082 035 $a(EBL)1964963 035 $a(OCoLC)907301155 035 $a(SSID)ssj0001386595 035 $a(PQKBManifestationID)11814663 035 $a(PQKBTitleCode)TC0001386595 035 $a(PQKBWorkID)11374315 035 $a(PQKB)10189863 035 $a(DE-He213)978-1-4939-1881-2 035 $a(MiAaPQ)EBC1964963 035 $a(PPN)183088867 035 $a(EXLCZ)993710000000281082 100 $a20141117d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aManagement of Bladder Cancer $eA Comprehensive Text With Clinical Scenarios /$fedited by Badrinath R. Konety, Sam S. Chang 205 $a1st ed. 2015. 210 1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2015. 215 $a1 online resource (474 p.) 300 $aDescription based upon print version of record. 311 08$a1-4939-1880-X 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aEpidemiology and natural history -- Screening for Bladder Cancer -- Pathology and Staging: Histopathology and Cytopathology -- Pathology and Staging: Genetics and Molecular Biology -- Imaging in Localized and Advanced Bladder Cancer -- New Imaging Techniques in Staging of Urothelial Carcinoma of the Bladder -- Socioeconomic issues and improved quality of care -- Quality of life measures -- Prognostication and risk assessment -- Clinical trials and emerging therapeutic strategies in bladder cancer -- Improved diagnostic techniques -- Clinical scenario: Microscopic hematuria and atypical cytology in a 68 year old man with normal upper tract imaging -- Localized surgical therapy and surveillance -- Clinical Scenario: Initial high grade Ta tumor -- Clinical Scenario: Recurrent Ta tumor -- Clinical Scenario: Rapidly growing, high volume, low grade Ta tumor -- Clinical Scenario: Low grade T1 tumor -- Intravesical therapy -- Clinical Scenario: Initial CIS -- Management of BCG Recurrent Bladder Cancer -- Clinical Scenario: Persistent CIS and HIGH Grade Ta Bladder Cancer after BCG -- Maurizio Brausi -- Clinical Scenario: Presentation and Management of Significant Side Effects from Bacillus Calmette-Guérin Bladder Instillation -- Guideline-based management of non-muscle invasive bladder cancer: comparison of the AUA, EAU, ICUD and NCCN guidelines -- Open Radical Cystectomy -- Robotic cystectomy -- Clinical Scenario: T2 bladder tumor -- Urinary Diversion: Open and robotic techniques -- Chemoradiotherapy -- Clinical Scenario: 53 year-old man with a solitary, 2 cm, high-grade T2 tumor and focal CIS in the bladder dome who wants bladder preservation -- Management of Bladder Cancer, role of chemotherapy and controversies surrounding its application -- Clinical Scenario: Large volume, non metastatic T2 bladder tumor -- The role of pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer -- Clinical Scenario: Unexpected positive nodes at radical cystectomy -- Surveillance andmonitoring -- Clinical Scenario: The Role of Perioperative Chemotherapy -- Management of Bladder Cancer with Pelvic Nodal Metastases After Complete Response to Chemotherapy -- Guideline based management muscle-invasive bladder cancer: NCCN, ICUD and EAU. 330 $aThis book provides a single, comprehensive reference source that incorporates the epidemiology, natural history, and the latest genetic and molecular biological findings of bladder cancer. This book discusses the diagnostic and staging evaluation of both non-muscle invasive and invasive bladder cancer and incorporates the new findings on markers for the diagnosis of bladder cancer. Risk stratified treatment of non-muscle invasive bladder cancer including various approaches to intravesical therapy are reviewed. Current guideline-based approaches to management and new data regarding diagnosis and prognostication of muscle invasive bladder cancer is analyzed and summarized. This book covers the application of chemotherapy for muscle invasive and advanced disease. The evidence-based application of multimodality therapy is highlighted. Gaps in current knowledge and important areas for clinical  research are highlighted. Authored by experts in their respective fields, Management of Bladder Cancer: A Comprehensive Text with Clinical Scenarios serves as an easy and complete reference source for clinicians, researchers, individuals in training, allied health professionals and medical students in the fields of Urology, Medical Oncology, Radiation Oncology, Basic and Translational Science and Epidemiology. 606 $aUrology 606 $aOncology 606 $aInterventional radiology 606 $aUrology 606 $aOncology 606 $aInterventional Radiology 615 0$aUrology. 615 0$aOncology. 615 0$aInterventional radiology. 615 14$aUrology. 615 24$aOncology. 615 24$aInterventional Radiology. 676 $a610 676 $a616.0757 676 $a616.6 676 $a616994 702 $aKonety$b Badrinath R$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aChang$b Sam S$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300210103321 996 $aManagement of Bladder Cancer$91867671 997 $aUNINA